6-K 1 fresenius_6k.htm FORM 6-K

 

SECURITIES AND EXCHANGE COMMISSION

 Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

 

Pursuant to Rule 13a-16 or 15d-16 of the

 Securities Exchange Act of 1934

 

For the month of April 2012

 

FRESENIUS MEDICAL CARE AG & Co. KGaA

 

(Translation of registrant’s name into English)

 

Else-Kröner Strasse 1

 61346 Bad Homburg

Germany

 (Address of principal executive offices)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F   S    Form 40-F   £ 

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):  ______

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ______

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

 Yes  £     No  S

 

If “Yes” is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82

 

 
 

 

 

On April 2, 2012 Fresenius Medical Care AG & Co. KGaA (the “Company”) issued an Investor News announcing the completion of the sale of Clinics.

 

EXHIBITS

 

Exhibit 99.1                   Investor News Release issued April 2, 2012.

 

 
 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

DATE: April 2, 2012

 

    Fresenius Medical Care AG & Co. KGaA,
    a partnership limited by shares, represented by:
         
    fresenius medical care management ag, its
    general partner
         
    By: /s/ Dr. Ben J. Lipps
      Name:   Dr. Ben J. Lipps
      Title: Chief Executive Officer and
        Chairman of the Management Board
        of the General Partner
         
    By: /s/ Michael Brosnan
      Name: Michael Brosnan
    Title: Chief Financial Officer and
        Member of the Management Board
        of the General Partner